Literature DB >> 26842589

Histopathological analysis of anaplastic thyroid carcinoma cases with long-term survival: A report from the Anaplastic Thyroid Carcinoma Research Consortium of Japan.

Mitsuyoshi Hirokawa1, Iwao Sugitani, Kennichi Kakudo, Atsuhiko Sakamoto, Takuya Higashiyama, Kiminori Sugino, Kazuhisa Toda, Satoshi Ogasawara, Seiichi Yoshimoto, Yasuhisa Hasegawa, Tsuneo Imai, Naoyoshi Onoda, Yorihisa Orita, Makoto Kammori, Keisei Fujimori, Hiroyuki Yamada.   

Abstract

The aim of this study was to clarify the histopathological features of anaplastic thyroid carcinoma in patients who achieved long-term survival. We reviewed 88 anaplastic thyroid carcinoma cases in which the patient survived less than 3 months (short-term survival), and 68 anaplastic thyroid carcinoma cases in which the patient survived more than one year (long-term survival) from the database of the Anaplastic Thyroid Carcinoma Research Consortium of Japan. We examined these cases both histologically and immunohistochemically. Six (6.8%) short-term survival cases and 27 (39.7%) long-term survival cases were considered not to be anaplastic thyroid carcinoma after central review. Of these, 12 were revised to papillary carcinoma with squamous cell carcinoma. In cases without chemotherapy, long-term survival was significantly more common if there was a pre-existing tumor, epithelial growth, or lymphocytic infiltration, and short-term survival was more common if neutrophilic infiltration was present. In cases with chemotherapy, long-term survival was significantly more common if epithelial growth or a squamous cell carcinoma component was present, whereas short-term survival was more common in cases with rhabdoid cells. Immunohistochemical results were not related to survival. Some long-term survival cases showed histological findings other than those typically associated with anaplastic thyroid carcinoma. The presence of a pre-existing tumor, epithelial growth, a squamous cell carcinoma component, no neutrophilic infiltration and lymphocytic infiltration may therefore be favorable prognostic factors in anaplastic thyroid carcinoma.

Entities:  

Mesh:

Year:  2016        PMID: 26842589     DOI: 10.1507/endocrj.EJ15-0705

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  9 in total

1.  Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.

Authors:  Alyaksandr V Nikitski; Susan L Rominski; Vincenzo Condello; Cihan Kaya; Mamta Wankhede; Federica Panebianco; Hong Yang; Daniel L Altschuler; Yuri E Nikiforov
Journal:  Thyroid       Date:  2019-08-16       Impact factor: 6.568

2.  Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature.

Authors:  Moira Ragazzi; Federica Torricelli; Benedetta Donati; Alessia Ciarrocchi; Dario de Biase; Giovanni Tallini; Eleonora Zanetti; Alessandra Bisagni; Elisabetta Kuhn; Davide Giordano; Andrea Frasoldati; Simonetta Piana
Journal:  Virchows Arch       Date:  2020-07-18       Impact factor: 4.064

3.  Primary Versus Secondary Anaplastic Thyroid Carcinoma: Perspectives from Multi-institutional and Population-Level Data.

Authors:  Tam N M Ngo; Trang T B Le; Thoa Le; Andrey Bychkov; Naoki Oishi; Chan Kwon Jung; Lewis Hassell; Kennichi Kakudo; Huy Gia Vuong
Journal:  Endocr Pathol       Date:  2021-09-24       Impact factor: 3.943

4.  Response to immunotherapy in a patient with anaplastic thyroid cancer: A case report.

Authors:  Luming Zheng; Ling Li; Qingqing He; Meng Wang; Yunhan Ma; Jian Zhu; Yanchen Li; Xiaokang Fu; Yaxuan Zhang
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

5.  Comparison of sonographic characteristics of primary thyroid lymphoma and anaplastic thyroid carcinoma.

Authors:  Li-Shuang Gu; Ning-Yi Cui; Yong Wang; Shu-Nan Che; Shuang-Mei Zou; Wen He; Jun-Ying Liu; Xuan-Tong Gong
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 6.  INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.

Authors:  Zhonghua Liu; Mukund Seshadri; Vishal Gupta; Antonios Papanicolau-Sengos; Mihai Merzianu
Journal:  Head Neck Pathol       Date:  2021-05-31

7.  EBV-associated lymphoepithelioma-like thyroid carcinoma with favorable outcome: case report with cytopathologic and histopathologic study.

Authors:  Chih-Yi Liu; Shih-Hung Huang
Journal:  Diagn Pathol       Date:  2018-06-09       Impact factor: 2.644

Review 8.  Emerging Biomarkers in Thyroid Practice and Research.

Authors:  Shipra Agarwal; Andrey Bychkov; Chan-Kwon Jung
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 9.  Uncommon Site of Metastasis and Prolonged Survival in Patients with Anaplastic Thyroid Carcinoma: A Systematic Review of the Literature.

Authors:  Aurora Mirabile; Matteo Biafora; Leone Giordano; Gianluigi Arrigoni; Maria Giulia Cangi; Italo Dell'Oca; Francesca Lira Luce; Davide Di Santo; Andrea Galli; Michele Tulli; Renata Mellone; Davide Valsecchi; Vanesa Gregorc; Mario Bussi
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.